Prothena Corp Public (PRTA) Short-term Investments (2019 - 2024)

Prothena Corp Public's (PRTA) quarterly Short-term Investments came in at $1.4 million in Q1 2024, little changed quarter-over-quarter from $1.4 million in Q4 2023.

Prothena Corp Public (PRTA) Short-term Investments (2019 - 2024) Analysis & Trends

Prothena Corp Public's Short-term Investments history runs 5 years deep, the most recent figure standing at $1.4 million for Q1 2024.

  • On a quarterly basis, Short-term Investments changed N/A year-over-year to $1.4 million in Q1 2024; TTM through Mar 2024 was $1.4 million, a N/A change from a year earlier, with the FY2023 full-year figure at $1.4 million, changed N/A from the prior year.
  • Short-term Investments held at $1.4 million in Q1 2024 per PRTA's latest filing, from $1.4 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.4 million in Q3 2020 and bottomed at $1.4 million in Q3 2020.
  • The 4-year median for Short-term Investments is $1.4 million (2020), against an average of $1.4 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Prothena Corp Public 458.13 Mn 128.67 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 1.35 Mn
Dec 31, 2023 1.35 Mn
Sep 30, 2023 1.35 Mn
Jun 30, 2023 1.35 Mn
Jun 30, 2021 1.35 Mn
Mar 31, 2021 1.35 Mn
Dec 31, 2020 1.35 Mn
Sep 30, 2020 1.35 Mn
Jun 30, 2019 1.35 Mn
Mar 31, 2019 1.35 Mn